Double-stranded oligonucleotide molecules to DDIT4 and methods of use thereof

Number of patents in Portfolio can not be more than 2000

United States of America

PATENT NO 10421962
APP PUB NO 20180010125A1
SERIAL NO

15433400

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Provided herein are double stranded nucleic acid molecules, compositions comprising same and methods of use thereof for the treatment of a subject wherein expression of DDIT4 is associated with the etiology or progression of a disease or disorder in the subject. The compounds are preferably chemically synthesized and modified dsRNA molecules.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
QUARK PHARMACEUTICALS INC6501 DUMBARTON CIRCLE FREMONT CA 94555

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Avkin-Nachum, Sharon Nes Zionna, IL 30 149
Feinstein, Elena Rehovot, IL 146 1572
Kalinski, Hagar Rishon le Zion, IL 47 370
Mett, Igor Rehovot, IL 73 671

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
7.5 Year Payment $3600.00 $1800.00 $900.00 Mar 24, 2027
11.5 Year Payment $7400.00 $3700.00 $1850.00 Mar 24, 2031
Fee Large entity fee small entity fee micro entity fee
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00